z-logo
open-access-imgOpen Access
Mycobacterial chaperonins: the tail wags the dog
Author(s) -
Colaco Camilo A.,
MacDougall Alistair
Publication year - 2014
Publication title -
fems microbiology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 151
eISSN - 1574-6968
pISSN - 0378-1097
DOI - 10.1111/1574-6968.12276
Subject(s) - chaperonin , groel , groes , operon , biology , protein folding , chaperone (clinical) , thermus , gene , genetics , foldase , computational biology , escherichia coli , heat shock protein , biochemistry , bacteria , thermophile , medicine , pathology
Molecular chaperones are defined as proteins that assist the noncovalent assembly of other protein‐containing structures in vivo , but which are not components of these structures when they are carrying out their normal biological functions. There are numerous families of protein that fit this definition of molecular chaperones, the most ubiquitous of which are the chaperonins and the Hsp70 families, both of which are required for the correct folding of nascent polypeptide chains and thus essential genes for cell viability. The groE genes of Escherichia coli were the first chaperonin genes to be discovered, within an operon comprising two genes, gro EL and gro ES , that function together in the correct folding of nascent polypeptide chains. The identification of multiple gro EL genes in mycobacteria, only one of which is operon‐encoded with a gro ES gene, has led to debate about the functions of their encoded proteins, especially as the essential copies are surprisingly often not the operon‐encoded genes. Comparisons of these protein sequences reveals a consistent functional homology and identifies an actinomycete‐specific chaperonin family, which may chaperone the folding of enzymes involved in mycolic acid synthesis and thus provide a unique target for the development of a new class of broad‐spectrum antimycobacterial drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here